Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes patients have been found to cause severe and debilitating joint pain, according to the U.S. Food and Drug Administration (FDA). What are DPP-4 Inhibitors? DPP-4 inhibitors like Januvia (sitagliptin), Onglyza (saxagliptin), Tradjenta (linagliptin), and Nesina (alogliptin) are used, […]
Feb 14, 2017
By Jessica Hoerman
Type 2 Diabetes Drugs